      
<!-- modules/module30.html -->
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Specific Antineoplastic Examples - KMTC Pharmacology Notes</title>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Specific Antineoplastic Examples - KMTC Pharmacology Notes</title>
    <meta name="description" content="This module provides examples of specific antineoplastic drugs such as Carboplatin and Cisplatin.">
</head>
<body>
    <article class="learning-module" data-module="30">
        <nav class="module-nav">
            <div class="nav-links">
              <a href="../index.html">Home</a>
              <a href="module29.html">Previous</a>
              <a href="module31.html">Next</a>
            </div>
            <div class="module-progress">
              <span>Module 30 of 89</span>
            </div>
          </nav>

        <header class="module-header">
            <h1>Specific Antineoplastic Examples</h1>
            <section class="module-objectives">
                <h2>üéØ Learning Objectives</h2>
                <ul>
                    <li>Describe the mechanism of action, uses, and side effects of Carboplatin.</li>
                    <li>Explain the therapeutic applications and adverse effects of Cyclophosphamide (CYC).</li>
                    <li>Discuss the uses and specific side effects of Ifosfamide.</li>
                    <li>Detail the mechanism of action, uses, and side effects of Cytarabine.</li>
                    <li>Explain the clinical applications and considerations for Methotrexate (MTX).</li>
                    <li>Describe the action and side effects of Cisplatin, including essential nursing considerations.</li>
                </ul>
            </section>
        </header>

        <main class="module-content">
            <section class="content-section">
                <h2>üìö Specific Antineoplastic Agents</h2>
                <div class="content-block">
                    <p>Let's explore specific examples of antineoplastic drugs, categorized by their mechanisms of action, to understand their clinical applications and nursing implications:</p>
                    <ol>
                        <li><strong>A) Alkylating Agents:</strong> These agents work by adding alkyl groups to DNA, which disrupts DNA replication and cell function.
                            <ul>
                                <li><strong>1. Carboplatin:</strong>
                                    <ul>
                                        <li>Trade name: Paraplatin.</li>
                                        <li>Class: Antineoplastic, alkylating agent.</li>
                                        <li>Uses: Primarily for ovarian cancer.</li>
                                        <li>Additional Side effects: Neurotoxicity and nephrotoxicity, in addition to common chemotherapy side effects.</li>
                                    </ul>
                                </li>
                                <li><strong>2. Cyclophosphamide (CYC) :</strong>
                                    <ul>
                                        <li>Trade name: Cytoxan.</li>
                                        <li>Class: Antineoplastic, alkylating agent.</li>
                                        <li>Uses: Effective against multiple myeloma, malignant lymphomas, and Hodgkin‚Äôs disease.</li>
                                        <li>Additional Side effects: Alopecia, bone marrow depression, hemorrhagic cystitis (bladder inflammation with bleeding), darkening of skin and fingernails.</li>
                                    </ul>
                                </li>
                                <li><strong>Ifosfamide:</strong>
                                    <ul>
                                        <li>Trade name: Ifex.</li>
                                        <li>Class: Antineoplastic, alkylating agent.</li>
                                        <li>Uses: Used to treat acute leukemia, testicular cancer, and malignant lymphomas.</li>
                                        <li>Additional Side effects: Hemorrhagic cystitis, similar to cyclophosphamide, but often more pronounced.</li>
                                    </ul>
                                </li>
                            </ul>
                        </li>
                        <li><strong>B) Antimetabolites:</strong> These drugs interfere with DNA replication by mimicking essential metabolites, disrupting DNA and RNA synthesis.
                            <ul>
                                <li><strong>1. Cytarabine:</strong>
                                    <ul>
                                        <li>Trade name: Cytosar.</li>
                                        <li>Class: Antineoplastic , antimetabolite.</li>
                                        <li>Uses: acute myelocytic leukemia, Hodgkin‚Äôs lymphoma.</li>
                                        <li>Additional Side effects: cytarbine syndrome occurs 6-12 hours following administration manifested by myalgia, fever, and bone pain.</li>
                                    </ul>
                                </li>
                                <li><strong>2. Methotrexate (MTX) :</strong>
                                    <ul>
                                        <li>Trade name: Abitexate.</li>
                                        <li>Class.: antimeabolite, folic acid analog.</li>
                                        <li>Action: similar to sulfonamide, it decreases purine and DNA synthesis.</li>
                                        <li>Uses: uterine choriocarcinoma (cancer of the placenta), vesicular mole, leukemia. In low doses for treatment of rheumatoid arthritis. Action isn‚Äôt known.</li>
                                        <li>Side effects: severe bone marrow depression, hepatotoxicity, hemorrhagic enteritis, transient paresis or seizures.</li>
                                        <li>Given intravenously and intrathecally.</li>
                                    </ul>
                                </li>
                            </ul>
                        </li>
                        <li><strong>C) Antibiotics:</strong> These drugs interfere with RNA, DNA, and protein synthesis in cancer cells.
                            <ul>
                                <li><strong>1) Bleomycin</strong></li>
                                <li><strong>2) Dactinomycin:</strong> actinomycin D .</li>
                                <li><strong>3) Doxorubicin:</strong> Adriamycin.</li>
                            </ul>
                        </li>
                        <li><strong>D) Natural products and miscellaneous agents:</strong> These include plant alkaloids and other agents with diverse mechanisms.
                            <ul>
                                <li><strong>1) Cisplatin:</strong>
                                    <ul>
                                        <li>Class.: antineoplsstic, miscellaneous.</li>
                                        <li>Side effect: Severe nausea and vomiting.</li>
                                        <li>Note: Hydrate patient by I.V. fluids 8-12 hours before treatment to minimize nephrotoxicity.</li>
                                    </ul>
                                </li>
                            </ul>
                        </li>
                    </ol>
                </div>
            </section>

            <section class="practice-activity">
                <h2>‚úçÔ∏è Practice Exercise</h2>
                <div class="activity-content">
                    <p><strong>Question:</strong> Compare and contrast the side effect profiles and primary uses of Carboplatin and Methotrexate. Which type of cancer is each primarily used to treat?</p>
                    <details class="solution">
                        <summary>View Solution</summary>
                        <div class="solution-content">
                            <p><strong>Comparison of Carboplatin and Methotrexate:</strong></p>
                            <ul>
                                <li><strong>Mechanism of Action:</strong>
                                    <ul>
                                        <li><strong>Carboplatin:</strong> Alkylating agent; damages DNA by forming crosslinks, leading to cell death.</li>
                                        <li><strong>Methotrexate:</strong> Antimetabolite; inhibits folic acid metabolism, disrupting DNA and RNA synthesis.</li>
                                    </ul>
                                </li>
                                <li><strong>Primary Cancer Uses:</strong>
                                    <ul>
                                        <li><strong>Carboplatin:</strong> Primarily used in the treatment of ovarian cancer. Also effective in lung, bladder, and testicular cancers.</li>
                                        <li><strong>Methotrexate:</strong> Used for uterine choriocarcinoma, vesicular mole, and leukemia. Also used in lower doses for non-cancerous conditions like rheumatoid arthritis.</li>
                                    </ul>
                                </li>
                                <li><strong>Side Effect Profiles:</strong>
                                    <ul>
                                        <li><strong>Carboplatin:</strong>
                                            <ul>
                                                <li>Common: Bone marrow depression (leading to anemia, leukopenia, thrombocytopenia), nausea and vomiting, alopecia.</li>
                                                <li>Specific: Neurotoxicity (peripheral neuropathy, ototoxicity) and nephrotoxicity. Nausea and vomiting can be severe but are generally manageable with antiemetics.</li>
                                            </ul>
                                        </li>
                                        <li><strong>Methotrexate:</strong>
                                            <ul>
                                                <li>Common: Severe bone marrow depression, hepatotoxicity, mucositis (stomatitis), nausea and vomiting, alopecia.</li>
                                                <li>Specific: Hemorrhagic enteritis (intestinal bleeding and inflammation), transient paresis (muscle weakness), and seizures. Hepatotoxicity and bone marrow suppression are major dose-limiting toxicities.</li>
                                            </ul>
                                        </li>
                                </li>
                            </ul>

                            <p><strong>Summary of Differences:</strong></p>
                            <ul>
                                <li><strong>Cancer Types:</strong> Carboplatin is a first-line treatment for ovarian cancer and other solid tumors. Methotrexate is key for choriocarcinoma, leukemia, and certain autoimmune diseases.</li>
                                <li><strong>Side Effects:</strong> Both cause significant bone marrow suppression and GI issues. Carboplatin is particularly noted for neuro- and nephrotoxicity, while Methotrexate is more associated with hepatotoxicity and severe mucositis.</li>
                                <li><strong>Nursing Implications:</strong> For both drugs, monitoring blood counts, renal and liver function, and managing nausea and vomiting are critical. For Methotrexate, monitoring for mucositis and ensuring leucovorin rescue (to mitigate bone marrow suppression) are also important. Hydration and monitoring for neurotoxicity are key for Carboplatin.</li>
                            </ul>
                        </div>
                    </details>
                </div>
            </section>
        </main>

        <footer class="module-footer">
            <section class="key-takeaways">
                <h2>üìö Key Takeaways</h2>
                <ul>
                    <li>Carboplatin is an alkylating agent mainly for ovarian cancer, with neuro- and nephrotoxicity as key side effects.</li>
                    <li>Cyclophosphamide, another alkylating agent, treats lymphomas and myeloma, notable for hemorrhagic cystitis and alopecia.</li>
                    <li>Ifosfamide, similar to cyclophosphamide, treats leukemia and lymphomas, also with a risk of hemorrhagic cystitis.</li>
                    <li>Cytarabine, an antimetabolite, treats acute leukemia and lymphoma, causing cytarabine syndrome with flu-like symptoms.</li>
                    <li>Methotrexate, another antimetabolite, treats choriocarcinoma and leukemia, with severe bone marrow depression and hepatotoxicity risks.</li>
                    <li>Cisplatin, a miscellaneous agent, is known for causing severe nausea and vomiting; hydration is crucial to prevent nephrotoxicity.</li>
                </ul>
            </section>

            <section class="knowledge-check">
                <h2>‚ö° Knowledge Check</h2>
                <div class="quiz-content">
                    <ol>
                        <li>Carboplatin is primarily used in the treatment of:
                            <br> a) Leukemia <br> b) Ovarian cancer <br> c) Lung cancer</li>
                        <li>Hemorrhagic cystitis is a notable side effect of which antineoplastic drug?
                            <br> a) Methotrexate <br> b) Cyclophosphamide <br> c) Cisplatin</li>
                        <li>Cytarabine syndrome, characterized by myalgia and fever, occurs after administration of:
                            <br> a) Carboplatin <br> b) Cytarabine <br> c) Methotrexate</li>
                    </ol>
                </div>
            </section>
        </footer>
    </article>
</body>
</html>

    